KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) EPS (Basic): 2015-2024

Historic EPS (Basic) for Medpace Holdings (MEDP) over the last 10 years, with Dec 2024 value amounting to $13.06.

  • Medpace Holdings' EPS (Basic) rose 27.01% to $3.95 in Q3 2025 from the same period last year, while for Sep 2025 it was $14.66, marking a year-over-year increase of 23.92%. This contributed to the annual value of $13.06 for FY2024, which is 41.96% up from last year.
  • As of FY2024, Medpace Holdings' EPS (Basic) stood at $13.06, which was up 41.96% from $9.20 recorded in FY2023.
  • In the past 5 years, Medpace Holdings' EPS (Basic) registered a high of $13.06 during FY2024, and its lowest value of $4.07 during FY2020.
  • Over the past 3 years, Medpace Holdings' median EPS (Basic) value was $9.20 (recorded in 2023), while the average stood at $9.94.
  • Data for Medpace Holdings' EPS (Basic) shows a peak YoY spiked of 49.60% (in 2022) over the last 5 years.
  • Medpace Holdings' EPS (Basic) (Yearly) stood at $4.07 in 2020, then climbed by 24.32% to $5.06 in 2021, then soared by 49.60% to $7.57 in 2022, then grew by 21.53% to $9.20 in 2023, then surged by 41.96% to $13.06 in 2024.